PNLIP and obesity due to melanocortin 4 receptor deficiency: Understanding the potential of Cu-GO nanocomposites in mitigating obesity-related processes involved evaluating their anti-obesity activity through the inhibition of pancreatic lipase enzyme (Figure 11).